Brain zaps show promise for stuttering relief
NCT ID NCT06278233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a mild electrical current applied to the scalp for 5 days in a row could help adults who stutter speak more fluently. 36 participants received either real or sham stimulation while doing fluency exercises. Researchers measured changes in stuttering during reading and conversation right after treatment and one week later.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial direct current stimulation (tDCS)
- What this could lead to
- If it works, this could point toward a non-invasive, drug-free treatment to improve fluency in adults who stutter.
- What could go wrong
- This is a small, early-stage study with only 36 participants. The effects may be temporary or not work for everyone. More research is needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
36 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Jul 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * developmental stuttering * age between 18 and 60 years * right hand dominant Exclusion Criteria: * history of seizures, head trauma, hearing problems, cochlear implant, intracranial metal implantation, medications that affects the central nervous system, implanted neurostimulators, cardiac pacemakers, or medication infusion devices * any speech and language disorder other than developmental stuttering * neurological or psychiatric disorders, brain surgery, tumours, neurodevelopmental disorders, or attention deficit hyperactivity disorder
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stuttering, adult are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biruni University
Istanbul, Zeytinburnu, 34015, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a once-daily pill ease stuttering? a trial puts lumateperone to the test.
- Brain scans and speech tasks aim to unlock the secrets of stuttering
- Can an app help people who stutter speak more fluently?
- Brain zaps for stuttering? tiny trial tests rTMS
- Brain scans reveal how stuttering works in new drug study
- Brain zaps may unlock fluency for people who stutter